Invex Therapeutics Ltd.ASX: IXC

First US Clinical Site Activated in IIH EVOLVE Phase III

Jan 19, 2023 at 3:53 AM UTC · Issued by Invex Therapeutics Ltd.

Invex Therapeutics Ltd has released a press release.

View Attachment